期刊文献+

肥厚型梗阻性心肌病经酒精室间隔消融术后心脏结构及功能变化 被引量:3

Changes of cardiac structure and function in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal alcohol septal myocardial ablation
下载PDF
导出
摘要 目的探讨经皮穿刺腔内酒精室间隔心肌消融术(percutaneous transluminal alcohol septal myocardial ablation,PTSMA)对肥厚型梗阻性心肌病(hypertrophic obstructive cardiomyopathy,HOCM)患者心脏结构及功能的影响。方法收集2006年1月至2012年12月在成都市第三人民医院住院的HOCM患者24例,比较其PTSMA术前、术后3个月及术后12个月的左心室流出道压力阶差、室间隔厚度、左心室后壁厚度、左心房内径、左心室舒张末期内径、纽约心脏病协会(NYHA)心功能分级、左心室射血分数和左心室短轴缩短率的变化。结果 HOCM患者进行PTSMA术后3个月及术后12个月左心室流出道压力阶差、室间隔厚度、左心室后壁厚度、左心房内径、左心室舒张末期内径、纽约心脏病协会心功能分级、左心室射血分数和左心室短轴缩短率与术前比较,差异有统计学意义(P<0.05);术后12个月相比术后3个月,以上指标变化差异无统计学意义(P>0.05)。结论 PTSMA能显著改善HOCM患者左心室流出道梗阻及降低室壁厚度,改善患者心功能,是有效的治疗方法。 Objectives To explore the effect of percutaneous transluminal alcohol septal myocardial ablation (PTSMA)on cardiac function and structure in patients with hypertrophic obstructive cardiomyopathy (HOCM).Methods Totally 24 HOCM patients were collected in the Third People's Hospital of Chengdu from January 2006 to December 2012.Left ventricular outflow tract gradient,interventricular septal thickness,left ventricular posterior wall thickness,left atrial diameter,left ventricular end-diastolic diameter,New York Heart Association (NYHA) heart functional classification,left ventricularejectionfraction (LVEF) and leftventricularfractionalshortening (LVFS) were comparedatthetime points of pre-operation,3 and 12 months post-operation.Results Left ventricular outflow tract gradient,interventricular septal thickness,left ventricular posterior wall thickness,left atrial diameter,left ventricular end-diastolic diameter,NYHA heart functional classification,LVEF and LVFS in HOCM patients were significantly different at the time points of 3 and 12 months post-operation compared with those pre-operation (P〈0.05).There was no significance difference of these indexes between 12 months and 3 months post-operation.Conclusions PTSMA can significantly moderate left ventricular outflow tract obstruction,reduce ventricular wall thickness and improve cardiac function in HOCM patients,which is an effective treatment approach.
出处 《岭南心血管病杂志》 2014年第5期622-624,669,共4页 South China Journal of Cardiovascular Diseases
基金 四川省卫生厅科研基金项目(项目编号:120538)
关键词 肥厚型心肌病 室间隔化学消融术 左心室流出道梗阻 室间隔 心功能 hypertrophic cardiomyopathy percutaneous transluminal septal myocardial ablation left ventricular outflow tract obstruction interventricular septum cardiac function
  • 相关文献

参考文献10

  • 1LEONARDI R A,TOWNSEND J C,PATEL C A,et al.Alcohol septal ablation for obstructive hypertrophiccardiomyopathy : outcomes in young, middle-aged, and elderlypatients[J]. Catheter Cardiovasc Interv, 2013,82(5): 838-845.
  • 2熊峰,刘春霞,唐炯.肥厚型心肌病的诊断与治疗进展[J].心血管病学进展,2013,34(5):686-689. 被引量:3
  • 3朱汉东,朱国英,苏晞,陈国洪,蔡建华,宋丹,彭剑.经皮腔内室间隔心肌消融术的远期随访[J].中华老年多器官疾病杂志,2011,10(2):121-124. 被引量:5
  • 4JENSEN M K,PRINZ C,HORSTKOTTE D, et al. Alcoholseptal ablation in patients with hypertrophic obstructivecardiomyopathy : low incidence of sudden cardiac death andreduced risk profile[J]. Heart, 2013, 99( 14) : 1012-1017.
  • 5LoPEZ-ABURTO G,PALACiOS-RODR GUEZ J M,CANT-RAM REZ S, et al. Septal alcohol ablation in patients withhypertrophic cardiomyopathy [J]. Rev Med Inst Mex SeguroSoc, 2013, 51(4): 396-401.
  • 6STEENDUK P,MELIGA E,VALGIMIGLI M,et al. Acuteeffects of alcohol septal ablation on systolic and diastolic leftventricular function in patients with hypertrophic obstructivecardiomyopathy [ J]. Heart, 2008,94( 10) : 1318-1322.
  • 7DABROWSKI M,CHOJNOWSKA L,MAE K, et al. Anassessment of regression of left ventricular hypertrophy followingalcohol ablation of the interventricular septum in patients withhypertrophic cardiomyopathy with left ventricular outflow tractobstruction[J]. Kardiol Pol, 2012, 70(8) : 782-788.
  • 8RIVERA S, SITGES M, AZQUETA M,et al. Left ventricularremodeling in patients with hypertrophic obstructivecardiomyopathy treated with percutaneous alcohol septalablation: an echocardiographic study [J]. Rev Esp Cardiol, 2003,56(12): 1174-1181.
  • 9WOJTAROWIGZ A,KORNACEWICZ-JACH Z,KA^MIERCZAKJ, et al. Doppler echocardiographic evaluation of left ventriculardiastolic function in patients with hypertrophic obstructivecardiomyopathy after alcohol septal ablation in acute and long-term follow up[J]. Pol Merkur Lekarski, 2002,13(73) : 25-28.
  • 10LEONARDI R A, KRANSDORF E P, SIMEL D L, et al.Meta-analyses of septal reduction therapies for obstructivehypertrophic cardiomyopathy : comparative rates of overallmortality and sudden cardiac death after treatment [J]. Circ Cardi-ovasc Interv, 2010, 3(2) : 97-104.

二级参考文献32

  • 1乔树宾,高润霖,尤士杰,袁建松,陈纪林,杨跃进.经皮室间隔化学消融术治疗肥厚梗阻型心肌病[J].中华内科杂志,2006,45(3):210-212. 被引量:13
  • 2王人彭,万海燕,苏骕,马小静,彭剑,宋丹,陈国洪,朱汉东,朱国英.经皮腔内室间隔心肌消融术治疗梗阻性肥厚型心肌病57例[J].中国介入心脏病学杂志,2006,14(2):111-114. 被引量:4
  • 3朱汉东,王人彭,苏唏,万海燕,彭剑,宋丹,陈国洪,朱国英.经皮腔内室间隔心肌消融术对心电指标的影响[J].生物医学工程与临床,2006,10(4):223-225. 被引量:1
  • 4蔡建华,苏唏,朱汉东,曾秋棠.60例梗阻性肥厚型心肌病化学消融治疗近期及中期疗效观察[J].临床心血管病杂志,2007,23(7):488-490. 被引量:5
  • 5Christiaans I, Birnie E, Bonsel GJ, et al. Manifest disease, risk factors for sud- den cardiac death, and cardiac events in a large nationwide cohort of predictive- ly tested hypertrophic cardiomyopathy mutation carriers: determining the best cardiological screening strategy [ J ]. Eur Heart J, 2011,32 ( 9 ) : 1161 - 1170.
  • 6Papadakis M, Carre F, Kervio G, et al. The prevalence, distribution, and clin- ical outcomes of electrocardiographic repolarization patterns in male athletes of Africart/Afre-Caribbean origin[J]. Eur Heart J,2011,32(18) : 2304-2313.
  • 7Jansen MK, Havndrup O, Christiansen M ,et al. Penetrance of hypertrophic car- diomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing [ J ]. Circulation, 2013,127 ( 1 ) : 48- 54.
  • 8Maron B J, Rowin EJ, Casey SA, et al. Risk stratification and outcome of patients with hypertrophic cardiomyopathy > = 60 years of age [ J ]. Circulation, 2013, 127 (5) : 585 -593.
  • 9Maron MS, Lesser JR, Maron BJ. Management implications of massive left van- trieular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance [ J ]. Am J Cardio1,2010,105 (12) : 1842-1843.
  • 10Maron MS, Olivotto I, Harrigan C, et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardlomyopathy [ ] ]. Circulation,2011,124 ( 1 ) :40-47.

共引文献6

同被引文献36

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部